As part of our ongoing series focussing on new registrations in Australia, we have added the first of a two-part series on the use of naltrexone/bupropion as a treatment for obesity.
This review discusses evidence supporting the use of naltrexone/bupropion in the management of obesity. It also provides commentary and recommendations from Dr Bobby Chan, an Endocrinologist working at South Sydney Medical Specialists and consulting in St George Private Hospital, Hurstville Private Hospital, Waratah Hospital and Kareena Hospital.
Please login below to download this issue (PDF)